SUN PHARMACEUTICAL INDUSTRIES INC 2023-06-14 Health serious FDA
Health · FDA · Recall #FDA-D-0869-2023
Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun… Recall
Issued June 14, 2023 · SUN PHARMACEUTICAL INDUSTRIES INC
In June 2023, SUN PHARMACEUTICAL INDUSTRIES INC recalled the Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations
What you should do
- 1 Stop using Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact SUN PHARMACEUTICAL INDUSTRIES INC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Health
- Recall date
- June 14, 2023
- Units affected
- Not reported
- Sold at
- Product was distributed to 19 distributors nationwide.
- Recall number
- FDA-D-0869-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- SUN PHARMACEUTICAL INDUSTRIES INC has 34 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.